AnaptysBio Inc logo

ANAB - AnaptysBio Inc News Story

$24.33 -0.6  -2.5%

Last Trade - 18/06/21

Sector
Healthcare
Size
Mid Cap
Market Cap £482.2m
Enterprise Value £206.8m
Revenue £51.6m
Position in Universe 3328th / 6927

AnaptysBio Inc expected to post a loss of 69  cents a share - Earnings Preview

Sat 1st May, 2021 3:08am
* AnaptysBio Inc  ANAB.OQ   ANAB.O  is expected to show a fall
in quarterly revenue when it reports results on May 4
(estimated).
* The San Diego, California-based company is expected to report
 a 37.4% decrease in revenue to $9.389 million from $15 million
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data.​​
​* Refinitiv's mean analyst estimate for AnaptysBio Inc is for a
loss of 69 cents per share. For the same quarter last year, the
company reported a loss of 30 cents per share.
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 
* The mean earnings estimate of analysts had risen by
about 30.8% in the last three months.​
* Wall Street's median 12-month price target for AnaptysBio Inc
is $26.5​, about 11.9% above​ its last closing price
of $23.35. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  1.41        1.39       1.20      Missed  -13.8
 Sep. 30 2020  -0.75       -0.72      -0.87     Missed  -20.6
 Jun. 30 2020  -0.76       -0.75      -0.79     Missed  -5.4​
 Mar. 31 2020  -0.62       -0.63      -0.30     Beat    52.4
 Dec.          -1.16​      -1.20      -0.75     Beat    37.3​
 31​ 2019​                                              
 Sep. 30 2019  -1.08       -1.15      -1.15     Met     -0.1​
 Jun. 30 2019  -0.98       -0.99      -0.89     Beat    9.8
 Mar. 31 2019  -0.81       -0.83      -0.82     Beat    0.7
 This summary was machine generated May 1 at 02:08 GMT.  All
figures in US dollars unless otherwise stated
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.